+86-28-82633987
EN
CN EN

Kobophenol A

BP4972
124027-58-3
98%
Phytopurify
Kobophenol A has antimicrobial, and anti-inflammatory activities, it might be a candidate for treatment of inflammatory bone diseases relevant to osteoblast cell death. Kobophenol A inhibits AChE activity in a dose-dependent manner, and the IC50 value is 115.8mM. Kobophenol A has protective effect against nitrosative/oxidative or mitochondrial damages resulted in the inhibition of the ROS, intracellular calcium ion level, and mitochondrial transmembrane potential changes on SH-SY5Y cells.Kobophenol A, identified through docking studies, is the first compound that inhibits SARS-CoV-2 binding to cells through blocking S1-RBD to the host ACE2 receptor and thus may serve as a good lead compound against COVID-19.
Catalog No Package Original Price Price Inventory Quantity Operating
BP4972-5mg 5mg $230.00
BP4972-10mg 10mg $390.00
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

Kobophenol A Related Products

Product drug property prediction parameters

  • 229.9900

  • 5.8726

  • 2.5694

  • .0030

  • 1.9056

  • 3.8959

  • Low

  • 92.9038

  • 5.1424

  • No

  • No

  • Yes

  • No

  • No

  • No

  • 0.0

  • Yes

  • Yes

  • Yes

  • Yes